Scarica l'app Stockscreener
6.14
14.34%
0.77
Dopo l'orario di chiusura:
6.12
-0.02
-0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.37
Aprire:
$5.52
Volume 24 ore:
751.97K
Relative Volume:
2.20
Capitalizzazione di mercato:
$317.37M
Reddito:
-
Utile/perdita netta:
$-19.90M
Rapporto P/E:
-11.58
EPS:
-0.53
Flusso di cassa netto:
$-19.80M
1 W Prestazione:
+7.53%
1M Prestazione:
+36.75%
6M Prestazione:
+0.99%
1 anno Prestazione:
+59.48%
Intervallo 1D:
$5.5014
$6.20
Intervallo di 1 settimana:
$5.14
$6.20
Portata 52W:
$3.19
$6.8184
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Nome
Diamedica Therapeutics Inc
Settore
Industria
Telefono
(763) 496-5454
Indirizzo
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Confronta DMAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.14 | 277.57M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-06-22 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Iniziato | Oppenheimer | Outperform |
| 2021-02-17 | Iniziato | ROTH Capital | Buy |
| 2020-10-30 | Iniziato | Guggenheim | Buy |
| 2020-07-08 | Iniziato | Maxim Group | Buy |
| 2019-04-30 | Iniziato | Dougherty & Company | Buy |
| 2019-03-05 | Iniziato | Lake Street | Buy |
Mostra tutto
Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie
Full technical analysis of DiaMedica Therapeutics Inc. stock2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Ranking DiaMedica Therapeutics Inc. among high performing stocks via toolsWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Is DiaMedica Therapeutics Inc. a candidate for recovery playWeekly Profit Report & Community Verified Trade Signals - Newser
Price momentum metrics for DiaMedica Therapeutics Inc. explainedMarket Growth Report & Risk Managed Trade Strategies - Newser
How institutional ownership impacts DiaMedica Therapeutics Inc. stockVolume Spike & Weekly High Momentum Picks - Newser
Is DiaMedica Therapeutics Inc. stock influenced by commodity pricesTrade Performance Summary & Daily Growth Stock Investment Tips - خودرو بانک
Does DiaMedica Therapeutics Inc. have declining or rising EPS2025 Earnings Impact & Safe Investment Capital Preservation Plans - خودرو بانک
Is DiaMedica Therapeutics Inc. forming higher highs and higher lows2025 Institutional Moves & Community Consensus Stock Picks - خودرو بانک
Published on: 2025-09-05 23:26:43 - خودرو بانک
Trend analysis for DiaMedica Therapeutics Inc. this weekWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Combining price and volume data for DiaMedica Therapeutics Inc.2025 Big Picture & Low Risk Entry Point Tips - Newser
Can DiaMedica Therapeutics Inc. sustain its profitabilityGap Up & Weekly Sector Rotation Insights - خودرو بانک
DiaMedica Therapeutics Stock (DMAC) Opinions on Insider Buying and Conference Presentations - Quiver Quantitative
Diamedica Therapeutics shares rise 3.35% premarket after announcing participation in upcoming investor conferences. - AInvest
DiaMedica Therapeutics: Investor Conferences as Catalysts for Biotech Sector Re-Rating - AInvest
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - AInvest
Using AI based signals to follow DiaMedica Therapeutics Inc.2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Volatility clustering patterns for DiaMedica Therapeutics Inc.July 2025 Summary & Daily Stock Momentum Reports - Newser
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million By Investing.com - Investing.com Canada
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million - Investing.com
Applying Elliott Wave Theory to DiaMedica Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Using data filters to optimize entry into DiaMedica Therapeutics Inc.2025 Retail Activity & Target Return Focused Stock Picks - Newser
Is DiaMedica Therapeutics Inc. forming a bullish divergenceJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Should you hold or exit DiaMedica Therapeutics Inc. now2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Understanding DiaMedica Therapeutics Inc.’s price movementRate Hike & Consistent Income Trade Ideas - Newser
How cyclical is DiaMedica Therapeutics Inc.’s revenue stream2025 Institutional Moves & Daily Market Momentum Tracking - خودرو بانک
Is DiaMedica Therapeutics Inc. stock a top performer YTD2025 Historical Comparison & High Return Stock Watch Alerts - خودرو بانک
Can DiaMedica Therapeutics Inc. hit a new high this monthRisk Management & High Conviction Trade Alerts - Newser
Published on: 2025-09-03 04:58:56 - Newser
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Quarterly Profit Report & Daily Profit Focused Screening - Newser
Is DiaMedica Therapeutics Inc. stock entering bullish territoryMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Published on: 2025-09-03 08:43:38 - خودرو بانک
Applying Wyckoff theory to DiaMedica Therapeutics Inc. stockShare Buyback & Consistent Income Trade Recommendations - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Can DiaMedica Therapeutics Inc. disrupt its industryTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
Is DiaMedica Therapeutics Inc. stock forming a cup and handleJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - خودرو بانک
Applying chart zones and confluence areas to DiaMedica Therapeutics Inc.2025 Risk Factors & High Win Rate Trade Alerts - Newser
Diamedica Therapeutics shares fall 2.28% intraday after announcing participation in Cantor Global Healthcare Conference. - AInvest
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference - Business Wire
Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):